✦ LIBER ✦

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

✍ Scribed by Valtorta, Emanuele; Misale, Sandra; Sartore-Bianchi, Andrea; Nagtegaal, Iris D.; Paraf, François; Lauricella, Calogero; Dimartino, Valentina; Hobor, Sebastijan; Jacobs, Bart; Ercolani, Cristiana; Lamba, Simona; Scala, Elisa; Veronese, Silvio; Laurent-Puig, Pierre; Siena, Salvatore; Tejpar, Sabine; Mottolese, Marcella; Punt, Cornelis J.A.; Gambacorta, Marcello; Bardelli, Alberto; Di Nicolantonio, Federica

Book ID: 120566879
Publisher: John Wiley and Sons
Year: 2013
Tongue: French
Weight: 367 KB
Volume: 133
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.28106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individualized therapies in colorectal c

Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy

✍ David Z Chang; Vikas Kumar; Ying Ma; Kuiyuan Li; Scott Kopetz 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 509 KB

A gene expression predictor of response

A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

✍ Justin M Balko; Esther P Black 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 657 KB

KRAS mutations in non-small-cell lung ca

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

✍ Maus, M.K.H.; Grimminger, P.P.; Mack, P.C.; Astrow, S.H.; Stephens, C.; Zeger, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 339 KB

KRAS mutation status in colorectal cance

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

✍ Rouleau, E; Spyratos, F; Dieumegard, B; Guinebretière, J M; Lidereau, R; Bièche, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

Effect of low-frequency KRAS mutations o

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

✍ Tougeron, D.; Lecomte, T.; Pages, J. C.; Villalva, C.; Collin, C.; Ferru, A.; To 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 159 KB

Emergence of KRAS mutations and acquired

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

✍ Misale, Sandra; Yaeger, Rona; Hobor, Sebastijan; Scala, Elisa; Janakiraman, Mani 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 704 KB